A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability issue of obesity medications such as Wegovy and Zepbound.

Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...

States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There’s also some ...

Durable medical equipment (DME) regulation can be tricky, so you must understand it. The Healthcare Common Procedure Coding System (HCPCS) codes define the rules, which are specific alphanumeric codes ...